Acadia Pharmaceuticals buy JPMorgan Chase & Co.
Start price
04.03.26
/
50%
€19.37
Target price
04.03.27
€29.31
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 04.03.27. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time.Performance without dividends (%)
| Name | 1w |
|---|---|
| Acadia Pharmaceuticals | - |
| iShares Core DAX® | -3.809% |
| iShares Nasdaq 100 | 0.487% |
| iShares Nikkei 225® | -4.418% |
| iShares S&P 500 | 0.251% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals (ACAD) had its price target raised by JPMorgan Chase & Co. from $31.00 to $34.00. They now have an "overweight" rating on the stock.
Ratings data for ACAD provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€20.43
17.11.25
17.11.25
€26.71
17.11.26
17.11.26
-1.76%
03.03.26
03.03.26
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€18.17
29.09.25
29.09.25
€28.15
29.09.26
29.09.26
6.60%
03.03.26
03.03.26
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€20.00
24.07.25
24.07.25
€28.88
24.07.26
24.07.26
-3.15%
03.03.26
03.03.26
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€19.28
06.06.25
06.06.25
€26.22
06.06.26
06.06.26
0.47%
03.03.26
03.03.26
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€16.50
25.03.24
25.03.24
€23.06
25.03.25
25.03.25
-4.67%
26.03.25
26.03.25